Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis E Hourcade

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|November 23, 2005
The role of properdin in the assembly of the alternative pathway C3 convertases of complementDennis E Hourcade
Current Drug Targets|February 22, 2008
Properdin and complement activation: a fresh perspectiveDennis E Hourcade
Molecular Immunology|August 12, 2008
Properdin: New roles in pattern recognition and target clearanceClaudia Kemper, Dennis E Hourcade
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 28, 2023
A Monoclonal Antibody That Provides a Model for C3 Nephritic FactorsDennis E Hourcade, Lynne M Mitchell
The Journal of Biological Chemistry|August 25, 2011
Access to the complement factor B scissile bond is facilitated by association of factor B with C3b proteinDennis E Hourcade, Lynne M Mitchell
Annual Review of Immunology|December 2, 2009
Properdin: emerging roles of a pattern-recognition moleculeClaudia Kemper, John P Atkinson, Dennis E Hourcade
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2008
The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosisClaudia Kemper, Lynne M Mitchell, Lijuan Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assemblyDirk Spitzer, Lynne M Mitchell, John P Atkinson, et al.
Open Glycoscience|July 20, 2010
The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue MethodsSarah B Frazier, Kevin A Roodhouse, Dennis E Hourcade, et al.
Molecular Immunology|August 12, 2015
Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidneyAnuja Java, M Kathryn Liszewski, Dennis E Hourcade, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|November 23, 2005
The role of properdin in the assembly of the alternative pathway C3 convertases of complementDennis E Hourcade
Current Drug Targets|February 22, 2008
Properdin and complement activation: a fresh perspectiveDennis E Hourcade
Molecular Immunology|August 12, 2008
Properdin: New roles in pattern recognition and target clearanceClaudia Kemper, Dennis E Hourcade
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 28, 2023
A Monoclonal Antibody That Provides a Model for C3 Nephritic FactorsDennis E Hourcade, Lynne M Mitchell
The Journal of Biological Chemistry|August 25, 2011
Access to the complement factor B scissile bond is facilitated by association of factor B with C3b proteinDennis E Hourcade, Lynne M Mitchell
Annual Review of Immunology|December 2, 2009
Properdin: emerging roles of a pattern-recognition moleculeClaudia Kemper, John P Atkinson, Dennis E Hourcade
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2008
The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosisClaudia Kemper, Lynne M Mitchell, Lijuan Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assemblyDirk Spitzer, Lynne M Mitchell, John P Atkinson, et al.
Open Glycoscience|July 20, 2010
The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue MethodsSarah B Frazier, Kevin A Roodhouse, Dennis E Hourcade, et al.
Molecular Immunology|August 12, 2015
Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidneyAnuja Java, M Kathryn Liszewski, Dennis E Hourcade, et al.
Pageof 3